In 2023, Torque Pharma expanded its export presence to Burkina Faso, a country of over 24 million people where children under 15 make up more than 40% of the population. For such a young population, access to healthcare plays a direct role in shaping healthier futures. Burkina Faso has already made progress, with stronger child survival and life expectancy rising to around 63.7 years. Torque Pharma supports this progress by improving access to quality pharmaceuticals from India. Through steady exports, we help strengthen treatment availability, care continuity, and healthier community outcomes.
Every shipment is packed for long-distance pharmaceutical transit, helping products remain protected from dispatch to final delivery.
Bulk shipments move through sea routes, while urgent requirements are handled through air dispatch when timelines matter.
Torque Pharma’s GMP and ISO-backed systems support the quality and safety that Burkina Faso’s patients & care providers depend on.
Torque Pharma helps Burkina Faso access quality Indian healthcare formulations at 30% to 90% lower pricing than Western equivalents.
